Skip to content

Risk study of nasal passage-related adverse events during pediatric nasotracheal intubation based on clinically available cone-beam computed tomography images

Risk study of nasal passage-related adverse events during pediatric nasotracheal intubation based on cone-beam CT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128648
Enrollment
Unknown
Registered
2026-07-23
Start date
2026-07-27
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal passage-related adverse events during pediatric nasotracheal intubation

Interventions

Sponsors

School and Hospital of Stomatology, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 2 to 18 years; 2. Children scheduled for elective oral, dental, or maxillofacial surgery under general anesthesia, with clinically planned nasotracheal intubation for airway management; 3. Children who have already undergone cone-beam computed tomography (CBCT) examination for clinical indications during routine clinical care, and whose CBCT images are available for retrieval and evaluation by the research team; 4. Written informed consent obtained from the legal guardian. For children with appropriate comprehension ability, age-appropriate explanation will be provided, and assent or willingness to cooperate will be obtained according to the requirements of the ethics committee.

Exclusion criteria

Exclusion criteria: 1.Events occurring between CBCT examination and surgery that may significantly alter nasal anatomy or nasal passage condition, such as nasal trauma, nasal or sinus surgery, or obvious acute nasal infection; 2.Severe craniofacial deformity, severe nasal anatomical abnormality, or other special conditions that make the routine nasotracheal intubation pathway clearly unsuitable or require special airway management strategies; 3.Obvious coagulation dysfunction, hematological disease, current use of anticoagulant or antiplatelet drugs, or other conditions that may significantly increase the risk of epistaxis.

Design outcomes

Primary

MeasureTime frame
Clinically relevant epistaxis;

Secondary

MeasureTime frame
Short-term postoperative safety outcomes (immediate post-extubation bleeding, PACU bleeding, alar pressure injury, recurrent epistaxis within 24h, serious adverse events);Failure of planned first nasal passage;

Countries

China

Contacts

Public ContactZhuge Jinru

School and Hospital of Stomatology, Wenzhou Medical University

zhugejinru1993@163.com+86 10 12345678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026